190 related articles for article (PubMed ID: 38600881)
1. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy.
Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI
Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881
[TBL] [Abstract][Full Text] [Related]
2. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
[No Abstract] [Full Text] [Related]
3. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.
Poupore N; Strat D; Mackey T; Brown K; Snell A; Nathaniel TI
Lipids Health Dis; 2020 May; 19(1):84. PubMed ID: 32375780
[TBL] [Abstract][Full Text] [Related]
4. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity.
Blum B; Penwell A; Wormack L; Walker B; Lari S; Nathaniel TI
Neurol Sci; 2019 Sep; 40(9):1829-1839. PubMed ID: 31049791
[TBL] [Abstract][Full Text] [Related]
5. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia.
Blum B; Wormack L; Holtel M; Penwell A; Lari S; Walker B; Nathaniel TI
BMC Womens Health; 2019 Jan; 19(1):11. PubMed ID: 30651099
[TBL] [Abstract][Full Text] [Related]
6. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
[TBL] [Abstract][Full Text] [Related]
7. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients.
Brecthel L; Gainey J; Penwell A; Nathaniel TI
BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy.
Knisely K; Sanders CB; Edrissi C; Rathfoot C; Poupore N; Bailey-Taylor MJ; Stewart B; Nathaniel T
J Vasc Nurs; 2022 Jun; 40(2):74-85. PubMed ID: 35750378
[TBL] [Abstract][Full Text] [Related]
9. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
[TBL] [Abstract][Full Text] [Related]
10. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke.
Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408
[TBL] [Abstract][Full Text] [Related]
12. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression.
Okon M; Blum B; Nathaniel TI
J Vasc Nurs; 2021 Dec; 39(4):91-99. PubMed ID: 34865727
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
Khedr EM; Abdelwarith A; Moussa G; Saber M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
16. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study.
Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y
J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528
[TBL] [Abstract][Full Text] [Related]
17. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
[TBL] [Abstract][Full Text] [Related]
18. Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke.
Cheng XD; Wang DZ; Zhang Q; Wang JH; Li BH; Zhang X; Zhang J; Zhou S; Jia LJ; Wang LR; Yu NW
BMC Neurol; 2023 Jun; 23(1):244. PubMed ID: 37353783
[TBL] [Abstract][Full Text] [Related]
19. A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy.
Jantasri S; Tiamkao S; Sawanyawisuth K
Clin Neurol Neurosurg; 2020 Nov; 198():106206. PubMed ID: 32932029
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis Therapy in Specialized and Non-specialized Stroke Units.
Blum B; Brechtel L; Nathaniel T
Arch Med Res; 2018 Nov; 49(8):588-597. PubMed ID: 30648540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
